API 0.74% $1.35 australian pharmaceutical industries limited

market expectations

  1. 2,105 Posts.
    lightbulb Created with Sketch. 41
    The market is waiting for the next play and the longer it takes the share price will obviously drift lower. It is in the interests of the next player to let this happen of course. Looking at the volumes going through it seems there are no white knights or strategic players taking stong positions.

    API are fighting back at an industry level and sources indicate picking up some of the "reactive" business losses of a few months ago. As a good percentage of owner - pharmacists own shares in API it is in their interest to be loyal despite their initial frustrations.

    I think there is a good chance API might live to fight another day.
 
watchlist Created with Sketch. Add API (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.